About: Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 January 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в січні 2009 (uk) scientific article published on 13 January 2009 (en) مقالة علمية نشرت في 13 يناير 2009 (ar)
publication date	wds:Q37069791-83A35E2A-117B-464C-8A57-50DAC3FD4420
publication date	2009-01-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37069791-1F57C40E-660C-4A8F-81BF-CDBB2EB8A69F
language of work or name	English
exact match	wds:Q37069791-CEBBFA31-4DC7-4C5B-A270-71B6BC2A917E
exact match	https://scigraph.springernature.com/pub.10.1186/1471-2407-9-14
cites work	wds:Q37069791-03322A85-733B-46B4-8BB8-0E93B731CC7E wds:Q37069791-0E09E953-9EE3-4230-A365-72AA1DFF66FC wds:Q37069791-1E5D19F5-A521-4B18-BB53-0E56826B61AA wds:Q37069791-1FA8296B-7736-40ED-A2B4-76B448046E56 wds:Q37069791-2A14244F-EC97-47BB-B1A2-9145028E0B44 wds:Q37069791-2D388375-40B2-4F82-8CD3-DCD4DC37FCCB wds:Q37069791-2E74472A-224F-4D39-B0D6-57CFA7A08B5A wds:Q37069791-3A95A474-59B5-4AFB-B8F0-5E3BDB1B8A7A wds:Q37069791-3CB8DF46-CD02-47C8-9F87-53E72EE0598B wds:Q37069791-420313DF-7D4A-4A1E-B6D0-2FF24BECBEBE wds:Q37069791-45209DE1-559E-47C8-A649-B7BA21ED5055 wds:Q37069791-85A5F9E2-3DD3-4A71-915A-DB5FDE06AF2E wds:Q37069791-9E7F9F7B-C7EA-4E3E-8325-EA74AC92CFB8 wds:Q37069791-AA15D4C0-1E49-48A6-8162-6B802D1E8C3E wds:Q37069791-B1802E1B-7257-462D-A821-0CFAA28D2CAF wds:Q37069791-BB72B0D2-E785-412E-887E-61239090C871 wds:Q37069791-C0499547-F476-44CE-9C3F-BCF630FEE819 wds:Q37069791-CF1F1D39-F0E6-498D-9B84-BCCAF5331ABF wds:Q37069791-D6346C74-84DD-4F79-8C2C-8C149B125FD8 wds:Q37069791-E3753C16-7423-4404-8AA0-DF9BCD6581D5 wds:Q37069791-EF4C7C4C-0F8E-421F-BABB-1E34749974C2
cites work	Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia
author name string	wds:Q37069791-0AE09FF3-F448-4FDF-8610-422D84723FF3 wds:Q37069791-0CEF7B3F-DC77-442B-8D80-5CC9178286E0 wds:Q37069791-351F58C6-06FE-44F7-AC70-426608608924 wds:Q37069791-373C7ABB-DAC8-47AB-85CB-A20C55C60325 wds:Q37069791-4F9DC2F1-975F-4897-A839-A61C6BC2AA19 wds:Q37069791-87179C94-2500-4F94-B08B-736250DD02C6 wds:Q37069791-AC63CAFB-6283-4119-B938-DD639A6A26D1 wds:Q37069791-CFC2C89F-E8BF-441B-B650-00C00E6510A7 wds:Q37069791-D6A1E21A-F8C2-42F2-BA46-3C0E0A368041 wds:Q37069791-DCF52594-DC8F-4B61-8A3B-E50A117C5654
author name string	Philippe Jonveaux Marianne Debre Andre Baruchel Jean-Louis Stephan Jean-Michel Cayuela Edouard Le Gall Odile Lejars FRALLE group Francois Demeocq Marie-Francoise Auclerc
rdfs:label	Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study. (nl) Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study (en) Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study (ast)
skos:prefLabel	Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study. (nl) Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study (en) Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study (ast)
name	Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study. (nl) Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study (en) Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study (ast)
author	wds:Q37069791-1E9708B7-88B2-41CF-BA58-F487E39DC58F wds:Q37069791-3BE91250-5E4E-4BEF-A226-EB4EA80693A6 wds:Q37069791-7A850E2C-B36D-4B41-A5C5-86C0D5FF67A5 wds:Q37069791-7EBB67D9-552F-4EE2-BD2F-4A8C25715588 wds:Q37069791-8BA7B8D2-C7FC-4D8B-866E-9D48D74D7EAD wds:Q37069791-AB339D47-8899-45A5-A617-DB66331977DF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software